Literature DB >> 18480333

Immunoreactive cell wall proteins of Clostridium difficile identified by human sera.

Anne Wright1, Denise Drudy2, Lorraine Kyne3, Katherine Brown1, Neil F Fairweather1.   

Abstract

Clostridium difficile is a leading cause of nosocomial infection in the developed world, causing antibiotic-associated disease in susceptible populations. The identity of immunogenic proteins is important in understanding the pathogenesis of disease and in the design of vaccines. This study analysed the sera of six patients infected during a hospital outbreak of a C. difficile ribotype 017 strain. Using a proteomics-based approach, cell wall proteins were separated by two-dimensional PAGE, and immunoreactive proteins were revealed by reaction with patient sera. The identity of immunoreactive proteins was established by MS. Forty-two different proteins were identified in total. All patient sera reacted with at least one component of the surface-layer protein (SLP), four reacted with both components (high- and low-molecular-mass SLPs), and five reacted with one other cell wall protein, suggesting that these are immunodominant antigens. The role of these proteins as potential vaccine candidates and their roles in pathogenesis deserve further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480333     DOI: 10.1099/jmm.0.47532-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  33 in total

Review 1.  Vaccinology in the genome era.

Authors:  C Daniela Rinaudo; John L Telford; Rino Rappuoli; Kate L Seib
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

2.  Cwp22, a novel peptidoglycan cross-linking enzyme, plays pleiotropic roles in Clostridioides difficile.

Authors:  Duolong Zhu; Jessica Bullock; Yongqun He; Xingmin Sun
Journal:  Environ Microbiol       Date:  2019-06-28       Impact factor: 5.491

Review 3.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

4.  Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.

Authors:  Sergey S Seregin; Yasser A Aldhamen; David P W Rastall; Sarah Godbehere; Andrea Amalfitano
Journal:  Vaccine       Date:  2011-12-23       Impact factor: 3.641

5.  Clostridium difficile has two parallel and essential Sec secretion systems.

Authors:  Robert P Fagan; Neil F Fairweather
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

Review 6.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 7.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

8.  Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing.

Authors:  Kate E Dingle; Xavier Didelot; M Azim Ansari; David W Eyre; Alison Vaughan; David Griffiths; Camilla L C Ip; Elizabeth M Batty; Tanya Golubchik; Rory Bowden; Keith A Jolley; Derek W Hood; Warren N Fawley; A Sarah Walker; Timothy E Peto; Mark H Wilcox; Derrick W Crook
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

9.  Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile.

Authors:  Jonathan M Kirby; Helen Ahern; April K Roberts; Vivek Kumar; Zoe Freeman; K Ravi Acharya; Clifford C Shone
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

10.  A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein.

Authors:  Jenny E Emerson; Catherine B Reynolds; Robert P Fagan; Helen A Shaw; David Goulding; Neil F Fairweather
Journal:  Mol Microbiol       Date:  2009-07-28       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.